Arkadios Wealth Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.33M | Buy |
48,051
+2,301
| +5% | +$255K | 0.16% | 142 |
|
|
2025
Q1 | $5.13M | Buy |
45,750
+22,240
| +95% | +$2.49M | 0.19% | 120 |
|
|
2024
Q4 | $2.17M | Sell |
23,510
-10,473
| -31% | -$967K | 0.12% | 169 |
|
|
2024
Q3 | $2.85M | Sell |
33,983
-4,141
| -11% | -$347K | 0.16% | 131 |
|
|
2024
Q2 | $2.62M | Buy |
38,124
+11,204
| +42% | +$769K | 0.18% | 124 |
|
|
2024
Q1 | $1.97M | Sell |
26,920
-571
| -2% | -$41.8K | 0.15% | 147 |
|
|
2023
Q4 | $2.23M | Buy |
27,491
+9,204
| +50% | +$746K | 0.19% | 119 |
|
|
2023
Q3 | $1.37M | Buy |
18,287
+14,456
| +377% | +$1.08M | 0.13% | 169 |
|
|
2023
Q2 | $295K | Buy |
3,831
+196
| +5% | +$15.1K | 0.03% | 451 |
|
|
2023
Q1 | $302K | Buy |
3,635
+34
| +0.9% | +$2.82K | 0.04% | 434 |
|
|
2022
Q4 | $309K | Sell |
3,601
-870
| -19% | -$74.7K | 0.04% | 395 |
|
|
2022
Q3 | $276K | Buy |
+4,471
| New | +$276K | 0.04% | 402 |
|
|
2021
Q4 | – | Sell |
-2,493
| Closed | -$174K | – | 1042 |
|
|
2021
Q3 | $174K | Buy |
2,493
+676
| +37% | +$47.2K | 0.03% | 540 |
|
|
2021
Q2 | $125K | Buy |
1,817
+1,224
| +206% | +$84.2K | 0.02% | 664 |
|
|
2021
Q1 | $38K | Sell |
593
-74
| -11% | -$4.74K | 0.01% | 768 |
|
|
2020
Q4 | $38K | Sell |
667
-70
| -9% | -$3.99K | 0.01% | 608 |
|
|
2020
Q3 | $45.7K | Sell |
737
-1,122
| -60% | -$69.6K | 0.02% | 436 |
|
|
2020
Q2 | $143K | Buy |
1,859
+159
| +9% | +$12.3K | 0.08% | 205 |
|
|
2020
Q1 | $127K | Buy |
1,700
+900
| +113% | +$67.3K | 0.08% | 199 |
|
|
2019
Q4 | $53.4K | Buy |
+800
| New | +$53.4K | 0.03% | 307 |
|